International Journal of Oral Biology

  • 제32권2호
  • /
  • Pages.79-84
  • /
  • 2007
  • /
  • 1226-7155(pISSN)
  • /
  • 2287-6618(eISSN)
대한구강생물학회 (The Korean Academy of Oral Biology)
권호 표지

Mutantional analysis of tumor suppressor gene p53 in human oral squamous carcinoma cell line YD-9

  • Min, Ji-Hak (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Kim, Do-Kyun (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Lee, Moo-Hyung (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Bae, Moon-Kyoung (Department of Oral Physiology, School of Dentistry and Research Institute for Oral Biotechnology, Pusan National University) ;
  • Um, Kyung-Il (Department of Biology, College of Natural Science, Dong-A University) ;
  • Kwak, Hyun-Ho (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Park, Bong-Soo (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Kim, Gyoo-Cheon (Department of Oral Anatomy, School of Dentistry, Pusan National University)
  • 발행 : 2007.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Oral squamous carcinoma (OSC) is the most common malignant neoplasm of the oral mucosa. Although the etiology of OSC is not fully understood, accumulated evidences indicate that the activation of proto-oncogenes and the inactivation of tumor suppressor genes underlie the disease development. An OSC cell line, YD-9 was newly established and characterized. However, the mutational analysis of p53 gene was not performed. Thus, in this study, the presence of mutation in the p53 gene was examined by amplification of exon-4 to -8 and subsequent DNA sequencing. Two point mutations were found in exon-4 and -6: A to G, resulting in amino acid change Tyr to Cys in exon-4, and C to G, resulting in amino acid change Gly to Arg in exon-6, respectively. Any mutation was not found in the exon-5, -7 and -8. The presented results would contribute to basic research to understand the biological mechanism of OSC using YD-9 cells.

키워드

참고문헌

  1. Chiba, I., Takahashi, T., Nau, M.M.,, D'Amico, D., Curiel, D.T., Mitsudomi, T., Buchhagen, D.L., Carbone, D., Piantadosi, S., and Koga, H., et al: Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene 5: 1603-1610, 1990
  2. Easty, D.M., Easty, G.C., Carier, R.L., Monghan, P., and Butler, L.J.: Ten human carcinoma cell lines derived from squamouse carcinomas of the head and neck. Br. J. Cancer 43: 772-785, 1981 https://doi.org/10.1038/bjc.1981.115
  3. Eliyahu, D., Raz, A., Gruss, P., Givol, D., and Oren, M.: Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 312: 646-649, 1984 https://doi.org/10.1038/312646a0
  4. Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., and Oren, M.: Wild-type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. U S A 86: 8763-8767, 1989
  5. Hollstein, M.C., Metcalf, R.A., Welsh, J.A., Montesano. R., and Harris, C.C.: Frequent mutation of the p53 gene in human esophageal cancer. Proc. Natl. Acad. Sci. U S A 87: 9958-9961, 1990
  6. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J., and Harris, C.C.: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350: 427-428, 1991 https://doi.org/10.1038/350427a0
  7. Hu, C., Hsieh, J., Kwang, C., Wang, P., Wang, C., Chen, C., Lo, S.J., Wuu, K., and Chang, C.: Biologic properties of three newly established human oesophageal carcinoma lines. J. Natl. Cancer Inst. 72: 577-583, 1984
  8. Husain, Z., Fei, Y.B., Roy, S., Solt, D.B., Polverini, P.J., and Biswas, D.K.: Sequential expression and cooperative interaction of c-Ha-ras and c-erbB genes in in vivo chemical carcinogenesis. Proc. Natl. Acad.. Sci. U S A 86: 1264-1268, 1989
  9. Jenkins, J.R., Rudge, K., Chumakov, P., and Currie, G.A.: The cellular oncogene p53 can be activated by mutagenesis. Nature. 317: 816-818, 1985 https://doi.org/10.1038/317816a0
  10. Ji, Z.W., Oku, N., Umeda, M., and Komori, T.: Establishment of an oral squamous cell carcinoma cell line (NOS-1) exhibiting amplification of the erbB-oncogene and point mutation of p53 tumor suppressor gene: its biological characteristics and animal model of local invasion by orthotopic transplantation of the cell line. Oral Oncology 37: 386-392, 2001 https://doi.org/10.1016/S1368-8375(00)00088-9
  11. Kim, M.S., LiS-L, Bertolami, C.N., Cherrick, H.M., and Park, N.H.: State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines. Anticancer Res. 13: 1405- 1414, 1993
  12. Lavigueur, A., Maltby, V., Mock, D., Rossant, J., Pawson,T., and Bernstein, A.: High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol.. Cell Biol. 9: 3982-3991, 1989
  13. Lee, E.J., Kim, J., Lee, S.A., Kim, E.J., Chun, Y.C., Ryu, M.H., and Yook, J.I..: Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp. Mol. Med. 37: 379-390, 2005 https://doi.org/10.1038/emm.2005.48
  14. Matlashewski, G.: The cell biology of human papillomavirus transformed cells. Anticancer Res.. 9: 1447-1456, 1989
  15. Mercer, W.E., Shields, M.T., Lin, D., Appella, E., and Ullrich, S.J.: Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferatingcell nuclear antigen expression. Proc. Natl. Acad. Sci. USA 88: 1958-1962, 1991
  16. Rodrigues, N.R., Rowan, A., Smith, M.E., Kerr, I.B., Bodmer, W.F., Gannon, J.V., and Lane, D.P.: p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA 87: 7555-7559, 1990
  17. Romano, J.W., Ehrhart, J.C., Duthu, A., Kim, C.M., Appella, E., and May, P.: Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line. Oncogene 4: 1483-1488, 1989
  18. Rovinski, B., Munroe, D., Peacock, J., Mowat, M., Bernstein, A. and, Benchimol, S.: Deletion of 5'-coding sequences of the cellular p53 gene in mouse erythroleukemia: a novel mechanism of oncogene regulation. Mol. Cell Biol. 7: 847- 853, 1987 https://doi.org/10.1128/MCB.7.2.847
  19. Sakai, H., Kawano, K., Okamura, K., and Hashimoto, N.: Immunohistochemical localization of c-myc oncogene product and EGF receptor in oral squamous cell carcinoma. J. Oral Pathol. Med. 19: 1-4, 1990 https://doi.org/10.1111/j.1600-0714.1990.tb00773.x
  20. Scheffner, M., Munger, K., Byrne, J.C., and Howley, P.M.: The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc .Natl. Acad. Sci. U S A 88: 5523- 5527, 1991
  21. Wong, D.T., and Biswas, D.K:. Expression of c-erbB protooncogene during dimethylbenzanthracene-induced tumorigenesis in hamster cheek pouch. Oncogene 2: 67-72, 1987